TRAP-Paclitaxel for Equine Eyelid Squamous Cell Carcinoma
Principle Investigator Dr. Annie Oh Description This is a dose-escalation clinical trial to determine the effectiveness of a novel chemotherapeutic drug, TRAP-Paclitaxel, for the treatment of equine squamous cell carcinoma (SCC). The study will consist of an initial visit with biopsy, and 1-3 injections of TRAP-Paclitaxel at a minimum of 6 weeks apart. Horses will […]
SHARE